儿童抑郁症

Zuckerbrot RA, Cheung A, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics. 2018 Mar;141(3):e20174081.全文  摘要

Walter HJ, Abright AR, Bukstein OG, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. J Am Acad Child Adolesc Psychiatry. 21Oct 2022 [Epub ahead of print].全文  摘要

National Institute for Health and Care Excellence. Depression in children and young people: identification and management. Jun 2019 [internet publication].全文

Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part II. Treatment and ongoing management. Pediatrics. 2018 Mar;141(3):e20174082.全文  摘要

Locher C, Koechlin H, Zion SR, et al. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Oct 1;74(10):1011-20.全文  摘要

Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008 Feb 27;299(8):901-13.全文  摘要

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

2. World Health Organization. ICD-11 for mortality and morbidity statistics (ICD-11 MMS). Feb 2022 [internet publication].全文

3. Ghandour RM, Sherman LJ, Vladutiu CJ, et al. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019 Mar;206:256-67.全文  摘要

4. Avenevoli S, Swendsen J, He JP, et al. Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment. J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):37-44.全文  摘要

5. Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015 Jul;40(4):219-21.全文  摘要

6. Hankin BL, Young JF, Abela JR, et al. Depression from childhood into late adolescence: influence of gender, development, genetic susceptibility, and peer stress. J Abnorm Psychol. 2015 Nov;124(4):803-16.全文  摘要

7. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602.全文  摘要

8. Lawrence D, Hafekost J, Johnson SE, et al. Key findings from the second Australian child and adolescent survey of mental health and wellbeing. Aust N Z J Psychiatry. 2016 Sep;50(9):876-86.全文  摘要

9. Jack RH, Hollis C, Coupland C, et al. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: a population-based cohort study. PLoS Med. 2020 Jul 22;17(7):e1003215.全文  摘要

10. Wijlaars LP, Nazareth I, Petersen I. Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). PLoS One. 2012;7(3):e33181.全文  摘要

11. Pumariega AJ, Roth EM, Rogers KM. Depression in immigrant and minority children and youth. In: Rey JM, Birmaher B, eds. Treating child and adolescent depression. Baltimore, MD: Lippincott Williams & Wilkins; 2009:321-31.

12. Pinquart M, Shen Y. Depressive symptoms in children and adolescents with chronic physical illness: an updated meta-analysis. J Pediatr Psychol. 2011 May;36(4):375-84.全文  摘要

13. Beardslee WR, Gladstone TR, O'Connor EE. Transmission and prevention of mood disorders among children of affectively ill parents: a review. J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1098-109. 摘要

14. Thapar A, Collishaw S, Pine DS, et al. Depression in adolescence. Lancet. 2012 Mar 17;379(9820):1056-67.全文  摘要

15. Harkness KL, Alavi N, Monroe SM, et al. Gender differences in life events prior to onset of major depressive disorder: the moderating effect of age. J Abnorm Psychol. 2010 Nov;119(4):791-803.全文  摘要

16. Keenan K, Hipwell A, Babinski D, et al. Examining the developmental interface of cortisol and depression symptoms in young adolescent girls. Psychoneuroendocrinology. 2013 Oct;38(10):2291-9.全文  摘要

17. Owens M, Herbert J, Jones PB, et al. Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3638-43.全文  摘要

18. Ruttle PL, Shirtcliff EA, Serbin LA, et al. Disentangling psychobiological mechanisms underlying internalizing and externalizing behaviors in youth: longitudinal and concurrent associations with cortisol. Horm Behav. 2011 Jan;59(1):123-32.全文  摘要

19. Ryan ND, Birmaher B, Perel JM, et al. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression: depressed vs normal children. Arch Gen Psychiatry. 1992 Nov;49(11):843-51. 摘要

20. Byrum CE, Ahearn EP, Krishnan KR. A neuroanatomic model for depression. Prog Neuropsychopharmacol Biol Psychiatry. 1999 Feb;23(2):175-93. 摘要

21. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):471-81. 摘要

22. Emslie GJ, Rush AJ, Weinberg WA, et al. Children with major depression show reduced rapid eye movement latencies. Arch Gen Psychiatry. 1990 Feb;47(2):119-24. 摘要

23. Emslie GJ, Rush AJ, Weinberg WA, et al. Sleep EEG features of adolescents with major depression. Biol Psychiatry. 1994 Nov 1;36(9):573-81. 摘要

24. Lahmeyer HW, Poznanski EO, Bellur SN. EEG sleep in depressed adolescents. Am J Psychiatry. 1983 Sep;140(9):1150-3. 摘要

25. Dahl RE, Puig-Antich J, Ryan ND, et al. EEG sleep in adolescents with major depression: the role of suicidality and inpatient status. J Affect Disord. 1990 May;19(1):63-75. 摘要

26. Rao U, Hammen CL, Poland RE. Risk markers for depression in adolescents: sleep and HPA measures. Neuropsychopharmacology. 2009 Jul;34(8):1936-45.全文  摘要

27. Armitage R, Hoffmann R, Emslie G, et al. Sleep microarchitecture in childhood and adolescent depression: temporal coherence. Clin EEG Neurosci. 2006 Jan;37(1):1-9. 摘要

28. Puig-Antich J, Goetz R, Hanlon C, et al. Sleep architecture and REM sleep measures in prepubertal children with major depression: a controlled study. Arch Gen Psychiatry. 1982 Aug;39(8):932-9. 摘要

29. Goetz RR, Puig-Antich J, Ryan N, et al. Electroencephalographic sleep of adolescents with major depression and normal controls. Arch Gen Psychiatry. 1987 Jan;44(1):61-8. 摘要

30. Forbes EE, Dahl RE. Neural systems of positive affect: relevance to understanding child and adolescent depression? Dev Psychopathol. 2005 Summer;17(3):827-50.全文  摘要

31. Maeng S, Zarate CA Jr. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep. 2007 Dec;9(6):467-74. 摘要

32. Beesdo K, Lau JY, Guyer AE, et al. Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry. 2009 Mar;66(3):275-85. 摘要

33. Forbes EE, Christopher May J, Siegle GJ, et al. Reward-related decision-making in pediatric major depressive disorder: an fMRI study. J Child Psychol Psychiatry. 2006 Oct;47(10):1031-40.全文  摘要

34. Steingard RJ, Yurgelun-Todd DA, Hennen J, et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry. 2000 Dec 1;48(11):1053-61. 摘要

35. Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53. 摘要

36. Weissman MM, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry. 2005 Jan;62(1):29-36.全文  摘要

37. Kendler KS, Gatz M, Gardner CO, et al. Age at onset and familial risk for major depression in a Swedish national twin sample. Psychol Med. 2005 Nov;35(11):1573-9. 摘要

38. Weissman MM, Warner V, Wickramaratne P, et al. Offspring of depressed parents: 10 years later. Arch Gen Psychiatry. 1997 Oct;54(10):932-40. 摘要

39. Ramchandani P, Stein A, Evans J, et al. Paternal depression in the postnatal period and child development: a prospective population study. Lancet. 2005 Jun 25-Jul 1;365(9478):2201-5. 摘要

40. Weissman MM, Wickramaratne P, Nomura Y, et al. Offspring of depressed parents: 20 years later. Am J Psychiatry. 2006 Jun;163(6):1001-8. 摘要

41. Lewis G, Neary M, Polek E, et al. The association between paternal and adolescent depressive symptoms: evidence from two population-based cohorts. Lancet Psychiatry. 2017 Dec;4(12):920-6.全文  摘要

42. McLeod BD, Weisz JR, Wood JJ. Examining the association between parenting and childhood depression: a meta-analysis. Clin Psychol Rev. 2007 Dec;27(8):986-1003. 摘要

43. Pilowsky DJ, Wickramaratne P, Nomura Y, et al. Family discord, parental depression, and psychopathology in offspring: 20-year follow-up. J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):452-60. 摘要

44. Buu A, Dipiazza C, Wang J, et al. Parent, family, and neighborhood effects on the development of child substance use and other psychopathology from preschool to the start of adulthood. J Stud Alcohol Drugs. 2009 Jul;70(4):489-98. 摘要

45. Puig-Antich J, Goetz D, Davies M, et al. A controlled family history study of prepubertal major depressive disorder. Arch Gen Psychiatry. 1989 May;46(5):406-18. 摘要

46. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003 Jul 18;301(5631):386-9. 摘要

47. American Academy of Pediatrics Committee On Adolescence. Office-based care for lesbian, gay, bisexual, transgender, and questioning youth. Pediatrics. 2013 Jul;132(1):198-203.全文  摘要

48. Burton CM, Marshal MP, Chisolm DJ, et al. Sexual minority-related victimization as a mediator of mental health disparities in sexual minority youth: a longitudinal analysis. J Youth Adolesc. 2013 Mar;42(3):394-402.全文  摘要

49. McLaughlin KA, Hatzenbuehler ML, Xuan Z, et al. Disproportionate exposure to early-life adversity and sexual orientation disparities in psychiatric morbidity. Child Abuse Negl. 2012 Sep;36(9):645-55.全文  摘要

50. Stewart SM, Rao U, White P. Depression and diabetes in children and adolescents. Curr Opin Pediatr. 2005 Oct;17(5):626-31. 摘要

51. Goodwin RD, Messineo K, Bregante A, et al. Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J Asthma. 2005 Oct;42(8):643-7. 摘要

52. Ballard CG, Davis R, Cullen PC, et al. Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br J Psychiatry. 1994 Jun;164(6):782-8. 摘要

53. Xie RH, He G, Koszycki D, et al. Prenatal social support, postnatal social support, and postpartum depression. Ann Epidemiol. 2009 Sep;19(9):637-43. 摘要

54. Deal LW, Holt VL. Young maternal age and depressive symptoms: results from the 1988 National Maternal and Infant Health Survey. Am J Public Health. 1998 Feb;88(2):266-70.全文  摘要

55. Barnett B, Morgan M. Postpartum psychiatric disorder: who should be admitted and to which hospital? Aust N Z J Psychiatry. 1996 Dec;30(6):709-14. 摘要

56. Fitzpatrick KM, Piko BF, Wright DR, et al. Depressive symptomatology, exposure to violence, and the role of social capital among African American adolescents. Am J Orthopsychiatry. 2005 Apr;75(2):262-74. 摘要

57. Fergusson DM, Boden JM, Horwood LJ. Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry. 2009 Mar;66(3):260-6. 摘要

58. Rao U. Links between depression and substance abuse in adolescents: neurobiological mechanisms. Am J Prev Med. 2006 Dec;31(6 suppl 1):S161-74. 摘要

59. Hetrick SE, Cox GR, Witt KG, et al. Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents. Cochrane Database Syst Rev. 2016 Aug 9;(8):CD003380.全文  摘要

60. Christensen H, Pallister E, Smale S, et al. Community-based prevention programs for anxiety and depression in youth: a systematic review. J Prim Prev. 2010 Jun;31(3):139-70. 摘要

61. Calear AL, Christensen H. Review of internet-based prevention and treatment programs for anxiety and depression in children and adolescents. Med J Aust. 2010 Jun 7;192(11 suppl):S12-4. 摘要

62. Whittaker R, Merry S, Stasiak K, et al. MEMO - a mobile phone depression prevention intervention for adolescents: development process and postprogram findings on acceptability from a randomized controlled trial. J Med Internet Res. 2012 Jan 24;14(1):e13. 摘要

63. Chun TH, Mace SE, Katz ER, et al. Evaluation and management of children with acute mental health or behavioral problems. Part II: recognition of clinically challenging mental health related conditions presenting with medical or uncertain symptoms. Pediatrics. 2016 Sep;138(3):e20161570.全文  摘要

64. Zuckerbrot RA, Cheung A, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics. 2018 Mar;141(3):e20174081.全文  摘要

65. US Preventive Services Task Force., Mangione CM, Barry MJ, et al. Screening for depression and suicide risk in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2022 Oct 18;328(15):1534-42.全文  摘要

66. Walter HJ, Abright AR, Bukstein OG, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. J Am Acad Child Adolesc Psychiatry. 21Oct 2022 [Epub ahead of print].全文  摘要

67. National Institute for Health and Care Excellence. Depression in children and young people: identification and management. Jun 2019 [internet publication].全文

68. Pinhas-Hamiel O, Doron-Panush N, Reichman B, et al. Obese children and adolescents: a risk group for low vitamin B12 concentration. Arch Pediatr Adolesc Med. 2006 Sep;160(9):933-6.全文  摘要

69. Reynolds WM. Reynolds adolescent depression scale. Odessa, FL: Psychological Assessment Resources; 1987.

70. Reynolds WM. Reynolds child depression scale. Odessa, FL: Psychological Assessment Resources; 1987.

71. Myers K, Winters NC. Ten-year review of rating scales. I: Overview of scale functioning, psychometric properties, and selection. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):114-22. 摘要

72. Angold A, Costello EJ, Messer SC, et al. The development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Meth Psychiatr Res. 1995;5:237-49.

73. Messer SC, Angold A, Loeber R, et al. The development of a short questionnaire for use in epidemiological studies of depression in children and adolescents: factor composition and structure across development. Int J Meth Psychiatr Res. 1995;5:251-62.

74. Katon W, Russo J, Richardson L, et al. Anxiety and depression screening for youth in a primary care population. Ambul Pediatr. 2008 May-Jun;8(3):182-8.全文  摘要

75. Beck AT, Steer RA. Beck Depression Inventory (BDI) Manual. 2nd ed. San Antonio, TX: Psychological Corporation; 1993.

76. Kovacs, M. Children’s depression inventory. North Tonawanda, NY: Multi-Health Systems, Inc; 1992.

77. Richardson LP, McCauley E, Grossman DC, et al. Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics. 2010 Dec;126(6):1117-23.全文  摘要

78. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part II. Treatment and ongoing management. Pediatrics. 2018 Mar;141(3):e20174082.全文  摘要

79. Hughes CW, Emslie GJ, Crismon ML, et al. Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jun;46(6):667-86. 摘要

80. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry. 2008 Apr;165(4):459-67.全文  摘要

81. Kroll L, Harrington R, Jayson D, et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 1996 Sep;35(9):1156-61. 摘要

82. Cheung A, Kusumakar V, Kutcher S, et al. Maintenance study for adolescent depression. J Child Adolesc Psychopharmacol. 2008 Aug;18(4):389-94. 摘要

83. Chun TH, Mace SE, Katz ER, et al. Evaluation and management of children and adolescents with acute mental health or behavioral problems. Part I: common clinical challenges of patients with mental health and/or behavioral emergencies. Pediatrics. 2016 Sep;138(3):e20161570.全文  摘要

84. Birmaher B, Brent D, AACAP Work Group on Quality Issues, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26. 摘要

85. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007 Sep-Oct;69(7):587-96.全文  摘要

86. Strohle A, Hofler M, Pfister H, et al. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol Med. 2007 Nov;37(11):1657-66. 摘要

87. Axelsdóttir B, Biedilae S, Sagatun Å, et al. Review: exercise for depression in children and adolescents - a systematic review and meta-analysis. Child Adolesc Ment Health. 2021 Nov;26(4):347-56. 摘要

88. Oberste M, Medele M, Javelle F, et al. Physical activity for the treatment of adolescent depression: a systematic review and meta-analysis. Front Physiol. 2020 Mar 19;11:185.全文  摘要

89. Kennard B, Silva S, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11. 摘要

90. Weisz JR, Kuppens S, Eckshtain D, et al. Performance of evidence-based youth psychotherapies compared with usual clinical care: a multilevel meta-analysis. JAMA Psychiatry. 2013 Jul;70(7):750-61.全文  摘要

91. Beardslee WR, Brent DA, Weersing VR, et al. Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry. 2013 Nov;70(11):1161-70.全文  摘要

92. Asarnow JR, Rozenman M, Wiblin J, et al. Integrated medical-behavioral care compared with usual primary care for child and adolescent behavioral health: a meta-analysis. JAMA Pediatr. 2015 Oct;169(10):929-37.全文  摘要

93. Weisz JR, Jensen-Doss A, Hawley KM. Evidence-based youth psychotherapies versus usual clinical care: a meta-analysis of direct comparisons. Am Psychol. 2006 Oct;61(7):671-89. 摘要

94. Goodyer IM, Dubicka B, Wilkinson P, et al. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors: the ADAPT trial. Health Technol Assess. 2008 May;12(14):iii-iv, ix-60. 摘要

95. Cox GR, Callahan P, Churchill R, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2014 Nov 30;2014(11):CD008324.全文  摘要

96. March JS, Silva S, Petrycki S, et al. The treatment for adolescents with depression study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007 Oct;64(10):1132-43.全文  摘要

97. Calati R, Pedrini L, Alighieri S, et al. Is cognitive behavioural therapy an effective complement to antidepressants in adolescents? A meta-analysis. Acta Neuropsychiatr. 2011 Dec;23(6):263-71. 摘要

98. Boaden K, Tomlinson A, Cortese S, et al. Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment. Front Psychiatry. 2020;11:717.全文  摘要

99. Hetrick SE, McKenzie JE, Bailey AP, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674.全文  摘要

100. Zhou X, Teng T, Zhang Y, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jul;7(7):581-601.全文  摘要

101. Viswanathan M, Kennedy SM, McKeeman J, et al.​ Treatment of depression in children and adolescents: a systematic review. Rockville (MD): Agency for Healthcare Research and Quality; 2020.全文  摘要

102. Locher C, Koechlin H, Zion SR, et al. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Oct 1;74(10):1011-20.全文  摘要

103. Nemeroff CB, Kalali A, Keller MB, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry. 2007 Apr;64(4):466-72.全文  摘要

104. Tao R, Emslie G, Mayes T, et al. Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):71-8.全文  摘要

105. Heiligenstein JH, Hoog SL, Wagner KD, et al. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):207-17. 摘要

106. Steinberg EM, Cardoso GM, Martinez PE, et al. Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety. 2012 Jun;29(6):531-40.全文  摘要

107. Gao SY, Wu QJ, Zhang TN, et al. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. Br J Clin Pharmacol. 2017 Oct;83(10):2134-47. 摘要

108. Wagner KD, Jonas J, Findling RL, et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):280-8. 摘要

109. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003 Aug 27;290(8):1033-41.全文  摘要

110. Wagner KD, Robb AS, Findling RL, et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry. 2004 Jun;161(6):1079-83. 摘要

111. Berard R, Fong R, Carpenter DJ, et al. An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):59-75. 摘要

112. Emslie GJ, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):709-19. 摘要

113. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72. 摘要

114. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007 Apr 18;297(15):1683-96. 摘要

115. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006 Mar;63(3):332-9.全文  摘要

116. Greenhill LL, Vitiello B, Fisher P, et al. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1488-96. 摘要

117. Vanderkooy JD, Kennedy SH, Bagby RM. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry. 2002 Mar;47(2):174-80. 摘要

118. Day JC, Wood G, Dewey M, et al. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry. 1995 May;166(5):650-3. 摘要

119. Chehil S, Kutcher S. Mental health therapeutic outcomes tool (TOT). 2007 [internet publication].全文

120. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008 Feb 27;299(8):901-13.全文  摘要

121. Emslie GJ, Findling RL, Yeung PP, et al. Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):479-88. 摘要

122. Mandoki MW, Tapia MR, Tapia MA, et al. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull. 1997;33(1):149-54. 摘要

123. Cooper WO, Callahan ST, Shintani A, et al. Antidepressants and suicide attempts in children. Pediatrics. 2014 Feb;133(2):204-10.全文  摘要

124. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry. 2005 Jul;46(7):735-54.全文  摘要

125. Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharm Des. 2006;12(23):2985-92. 摘要

126. Carvalho AF, Cavalcante JL, Castelo MS, et al. Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Ther. 2007 Oct;32(5):415-28. 摘要

127. Abraham G, Milev R, Stuart Lawson J. T3 augmentation of SSRI resistant depression. J Affect Disord. 2006 Apr;91(2-3):211-5. 摘要

128. Aronson R, Offman HJ, Joffe RT, et al. Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis. Arch Gen Psychiatry. 1996 Sep;53(9):842-8. 摘要

129. Papakostas GI. Augmentation strategies in the treatment of major depressive disorder: examining the evidence on augmentation with atypical antipsychotics. CNS Spectr. 2007 Dec;12(12 suppl 22):10-2. 摘要

130. Komossa K, Depping AM, Gaudchau A, et al. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008121.全文  摘要

131. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006 Mar 23;354(12):1243-52.全文  摘要

132. Kennard BD, Clarke GN, Weersing VR, et al. Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings. J Consult Clin Psychol. 2009 Dec;77(6):1033-41.全文  摘要

133. Carandang C, Robbins D, Mullany E, et al. Lamotrigine in adolescent mood disorders: a retrospective chart review. J Can Acad Child Adolesc Psychiatry. 2007 Feb;16(1):1-8.全文  摘要

134. Ryan ND, Meyer V, Dachille S, et al. Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry. 1988 May;27(3):371-6. 摘要

135. Strober M, Freeman R, Rigali J, et al. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):16-20. 摘要

136. Papanikolaou K, Richardson C, Pehlivanidis A, et al. Efficacy of antidepressants in child and adolescent depression: a meta-analytic study. J Neural Transm (Vienna). 2006 Mar;113(3):399-415. 摘要

137. DelBello MP, Hochadel TJ, Portland B,et al. A double-blind, placebo-controlled study of selegiline transdermal system (EMSAM) in depressed adolescents. Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Toronto, Canada; October 18-23, 2011.

138. Swedo SE, Allen AJ, Glod CA, et al. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):816-21. 摘要

139. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005 Apr;162(4):656-62.全文  摘要

140. Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry. 1997 May;154(5):595-602. 摘要

141. Cala S, Crismon ML, Baumgartner J. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy. 2003 Feb;23(2):222-30. 摘要

142. Fegert JM, Kolch M, Zito JM, et al. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):197-206. 摘要

143. Linde K, Mulrow CD, Berner M, et al. St John's wort for major depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000448.全文  摘要

144. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am. 2007 Mar;30(1):51-68. 摘要

145. Findling RL, McNamara NK, O'Riordan MA, et al. An open-label pilot study of St. John's wort in juvenile depression. J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):908-14. 摘要

146. Hübner WD, Kirste T. Experience with St John's wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res. 2001 Jun;15(4):367-70. 摘要

147. Simeon J, Nixon MK, Milin R, et al. Open-label pilot study of St. John's wort in adolescent depression. J Child Adolesc Psychopharmacol. 2005 Apr;15(2):293-301. 摘要

148. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007 Jul;68(7):1056-61. 摘要

149. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006 Jun;163(6):1098-100. 摘要

150. Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep. 2003 Dec;5(6):460-6. 摘要

151. Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.J Clin Psychopharmacol. 2004 Dec;24(6):661-4. 摘要

152. Schaller JL, Thomas J, Bazzan AJ. SAMe use in children and adolescents. Eur Child Adolesc Psychiatry. 2004 Oct;13(5):332-4. 摘要

153. Bloch Y, Grisaru N, Harel EV, et al. Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT. 2008 Jun;24(2):156-9. 摘要

154. D'Agati D, Bloch Y, Levkovitz Y, et al. rTMS for adolescents: safety and efficacy considerations. Psychiatry Res. 2010 May 30;177(3):280-5. 摘要

155. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002 Feb 15;51(4):280-7. 摘要

156. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000 Feb 15;47(4):276-86. 摘要

157. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001 Nov;25(5):713-28.全文  摘要

158. Sanacora G, Zarate CA Jr, Krystal JH, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008 May;7(5):426-37.全文  摘要

159. Zarate CA Jr, Singh JB, Quiroz JA, et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry. 2006 Jan;163(1):153-5. 摘要

160. Newport DJ, Carpenter LL, McDonald WM, et al. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015 Oct;172(10):950-66. 摘要

161. Short B, Fong J, Galvez V, et al. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018 Jan;5(1):65-78. 摘要

162. Zajecka J, Schatzberg A, Stahl S, et al. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2010 Apr;30(2):135-44. 摘要

163. Hale A, Corral RM, Mencacci C, et al. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. 摘要

164. Kasper S, Hajak G, Wulff K, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010 Feb;71(2):109-20. 摘要

165. Goodwin GM, Emsley R, Rembry S, et al. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009 Aug;70(8):1128-37. 摘要

166. Archer G, Kuh D, Hotopf M, et al. Adolescent affective symptoms and mortality. Br J Psychiatry. 2018 Jul;213(1):419-24.全文  摘要

167. Conwell Y, Duberstein PR, Cox C, et al. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry. 1996 Aug;153(8):1001-8. 摘要

168. Stanley B, Brown GK, Brenner LA, et al. Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry. 2018 Sep 1;75(9):894-900.全文  摘要

169. Morrato EH, Libby AM, Orton HD, et al. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008 Jan;165(1):42-50. 摘要